Stockscreener 앱 받기
33.55
5.51%
-1.958
시간 외 거래:
33.56
0.008
+0.02%
전일 마감가:
$35.51
열려 있는:
$35.12
하루 거래량:
1.25M
Relative Volume:
0.93
시가총액:
$1.75B
수익:
$2.82B
순이익/손실:
$-1.87B
주가수익비율:
-1.2026
EPS:
-27.9
순현금흐름:
$-96.80M
1주 성능:
+29.79%
1개월 성능:
+22.99%
6개월 성능:
-13.88%
1년 성능:
-24.06%
1일 변동 폭
$33.53
$35.45
1주일 범위
$28.54
$38.99
52주 변동 폭
$23.77
$49.45
Quidelortho Corporation Stock (QDEL) Company Profile
명칭
Quidelortho Corporation
전화
(858) 552-1100
주소
9975 SUMMERS RIDGE ROAD, SAN DIEGO, CA
QDEL을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
QDEL
Quidelortho Corporation
|
33.55 | 1.75B | 2.82B | -1.87B | -96.80M | -27.90 |
|
ABT
Abbott Laboratories
|
128.56 | 231.50B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
102.95 | 154.04B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
386.32 | 144.27B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
84.25 | 105.58B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
76.75 | 43.95B | 5.54B | 4.18B | 623.10M | 7.00 |
Quidelortho Corporation Stock (QDEL) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-05-08 | 업그레이드 | Jefferies | Hold → Buy |
| 2024-12-11 | 업그레이드 | Citigroup | Neutral → Buy |
| 2024-12-10 | 개시 | Jefferies | Hold |
| 2024-09-19 | 재개 | UBS | Neutral |
| 2024-09-05 | 업그레이드 | Craig Hallum | Hold → Buy |
| 2024-03-04 | 다운그레이드 | UBS | Neutral → Sell |
| 2024-02-14 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2023-12-11 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2022-12-12 | 업그레이드 | Citigroup | Neutral → Buy |
| 2022-12-07 | 개시 | RBC Capital Mkts | Outperform |
| 2022-10-14 | 업그레이드 | UBS | Sell → Neutral |
| 2022-09-19 | 개시 | Citigroup | Neutral |
| 2022-07-20 | 개시 | UBS | Sell |
| 2022-06-17 | 재개 | JP Morgan | Neutral |
| 2022-02-22 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2021-01-22 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2020-05-12 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2020-03-26 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2018-10-23 | 재개 | Raymond James | Strong Buy |
| 2018-03-08 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2018-01-22 | 재확인 | Barclays | Overweight |
| 2018-01-04 | 업그레이드 | CL King | Neutral → Buy |
| 2017-09-19 | 업그레이드 | Piper Jaffray | Neutral → Overweight |
| 2017-07-18 | 업그레이드 | Canaccord Genuity | Hold → Buy |
| 2017-07-18 | 업그레이드 | William Blair | Mkt Perform → Outperform |
| 2017-04-25 | 재확인 | Canaccord Genuity | Hold |
| 2017-02-17 | 개시 | CL King | Neutral |
| 2016-12-16 | 다운그레이드 | Piper Jaffray | Overweight → Neutral |
| 2016-06-13 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2016-02-18 | 재확인 | Barclays | Overweight |
| 2016-02-09 | 다운그레이드 | Canaccord Genuity | Buy → Hold |
| 2016-01-08 | 재확인 | Canaccord Genuity | Buy |
| 2015-12-14 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2015-09-02 | 개시 | Barclays | Overweight |
| 2013-07-31 | 재확인 | Canaccord Genuity | Buy |
| 2011-03-03 | 다운그레이드 | Wedbush | Outperform → Neutral |
모두보기
Quidelortho Corporation 주식(QDEL)의 최신 뉴스
Global Preeclampsia Diagnostics Market to Exhibit Growth at a CAGR of ~4% by 2032 | DelveInsight - GlobeNewswire Inc.
QuidelOrtho Corporation (NASDAQ:QDEL) Surges 32% Yet Its Low P/S Is No Reason For Excitement - simplywall.st
QuidelOrtho (QDEL) Faces Tariff Impact, Maintains 2025 Outlook - GuruFocus
Thermo Fisher, Biogen, Gilead Sciences, Moderna, and QuidelOrtho Stocks Trade Up, What You Need To Know - MSN
QuidelOrtho: Stagnant Growth Means Best To Avoid (Rating Downgrade) (NASDAQ:QDEL) - Seeking Alpha
Quidelortho sees $30M-$40M tariff impact offset, maintains 2025 guidance - MSN
QuidelOrtho Stock Gains Following Q1 Earnings Beat, Margins Expand - MSN
QuidelOrtho First Quarter 2025 Earnings: EPS Beats Expectations - simplywall.st
Jefferies upgrades QuidelOrtho to Buy, says ‘no news is good news’ - TipRanks
Why QuidelOrtho Corporation (QDEL) Went Up On Thursday - Yahoo Finance
10 Unexpected Market Movers – What Propelled Double-Digit Gains? - Insider Monkey
QuidelOrtho Earnings Call: Growth Amid Challenges - TipRanks
Jefferies Upgrades QuidelOrtho (QDEL) - Nasdaq
QuidelOrtho Corporation f/k/a Quidel Corporation Sued for Securities Law ViolationsInvestors Should Contact Levi & Korsinsky for More InformationQDEL - ACCESS Newswire
UBS Maintains Neutral Rating for QuidelOrtho (QDEL), Lowers Price Target | QDEL Stock News - GuruFocus
Why Is QuidelOrtho (QDEL) Stock Soaring Today - Yahoo Finance
QuidelOrtho (QDEL) Upgraded to Buy by Jefferies | QDEL Stock News - GuruFocus
QuidelOrtho Shares Gain After Q1 Adjusted Earnings Beat Consensus - marketscreener.com
Jefferies Elevates QuidelOrtho (QDEL) to Buy Rating Amid Positiv - GuruFocus
UBS Reduces Price Target for QuidelOrtho (QDEL) to $29 | QDEL Stock News - GuruFocus
UBS Cuts Price Target on QuidelOrtho to $29 From $45, Keeps Neutral Rating - marketscreener.com
QuidelOrtho Corporation (NASDAQ:QDEL) Q1 2025 Earnings Call Transcript - Insider Monkey
QuidelOrtho revenue increases 5% to USD 693M in Q1 2025 - Medical Buyer
QuidelOrtho's Q1 CY2025 Financial Performance: Revenue Decline and Profit GrowthNews and Statistics - IndexBox
QuidelOrtho Q1 Adjusted Earnings Rise, Revenue Falls; Fiscal 2025 Guidance Maintained - marketscreener.com
QuidelOrtho Corp (QDEL) Q1 2025 Earnings Call Highlights: Strong Growth in Core Segments Amid ... - Yahoo Finance
QuidelOrtho Corp (QDEL) Q1 2025 Earnings Call Highlights: Strong Growth in Core Segments Amid Revenue Decline - GuruFocus
QuidelOrtho: Q1 Earnings Snapshot - Norwalk Hour
QuidelOrtho Q1 2025 presentation slides: EPS surges 68% despite flat revenue By Investing.com - Investing.com South Africa
QuidelOrtho Reports Strong Q1 2025 Financial Results - TipRanks
QuidelOrtho Corp reports results for the quarter ended March 31Earnings Summary - TradingView
Earnings call transcript: QuidelOrtho Q1 2025 beats EPS, stock up 7.5% - Investing.com Australia
QuidelOrtho Q1 2025 presentation slides: EPS surges 68% despite flat revenue - Investing.com
QDEL Confident in Minimizing Tariff Impacts | QDEL Stock News - GuruFocus
QuidelOrtho (QDEL) Q1 Earnings and Revenues Top Estimates - Yahoo Finance
QuidelOrtho (NASDAQ:QDEL) Reports Q1 In Line With Expectations, Stock Soars - Yahoo Finance
QuidelOrtho (NASDAQ:QDEL) Reports Q1 In Line With Expectations - FinancialContent
QuidelOrtho sees FY25 Labs business growth in mid-single digits - TipRanks
Quidel shares surge 7.8% as Q1 earnings beat estimates By Investing.com - Investing.com Nigeria
QuidelOrtho (QDEL) Projects Steady Growth Across Key Segments for 2025 | QDEL Stock News - GuruFocus
Quidel shares surge 7.8% as Q1 earnings beat estimates - Investing.com Australia
QuidelOrtho (QDEL) Exceeds Q1 Revenue Expectations | QDEL Stock News - GuruFocus
QuidelOrtho Corp Q1 2025 Earnings: Adjusted EPS of $0.74 Beats Estimates, Revenue Hits $693 Million Surpassing Projections - GuruFocus
(QDEL) QUIDELORTHO CORPORATION Sees Q2 Adjusted EPS Range $2.07$2.57 - marketscreener.com
QuidelOrtho Reports First Quarter 2025 Financial Results - Stock Titan
QuidelOrtho (QDEL) Earnings Expected to Grow: Should You Buy? - MSN
MedTech Stocks' Earnings to Watch on May 7: COR, QDEL & INGN - TradingView
QuidelOrtho Earnings: What To Look For From QDEL - Yahoo Finance
Class Action Filed Against QuidelOrtho Corporation f/k/a Quidel Corporation (QDEL)June 11, 2024 Deadline to JoinContact Levi & Korsinsky - ACCESS Newswire
Quidelortho Corporation (QDEL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Quidelortho Corporation 주식 (QDEL) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Blaser Brian J. | President and CEO |
Dec 11 '24 |
Buy |
41.42 |
6,033 |
249,878 |
6,033 |
2.22%
2.87%
자본화:
|
볼륨(24시간):